Click Here for 5% Off Your First Aladdin Purchase!

JZL184 - ≥97%, high purity , CAS No.1101854-58-3, Inhibitor of Monoacylglycerol lipase

  • Moligand™
  • ≥97%
Item Number
J129444
Grouped product items
SKUSizeAvailabilityPrice Qty
J129444-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$34.90
J129444-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$142.90
J129444-100mg
100mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$474.90
J129444-250mg
250mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$1,068.90

Potent MAGL inhibitor

Basic Description

SynonymsJZL184|1101854-58-3|JZL 184|JZL-184|4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate|7MZ1I2J68A|CHEMBL576786|4-Nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate|1-Piperidinecarboxylic ac
Specifications & Purity≥97%
Storage TempStore at -20°C,Argon charged
Shipped InDry ice
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of Monoacylglycerol lipase
Product Description

application:

JZL 184 has been used as an inhibitor of monoacylglycerol lipase to study its effect on human osteoblast differentiation and proliferation and postsynaptic neurons.

Associated Targets

FAAH Tchem Fatty-acid amide hydrolase 1 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MGLL Tchem Monoglyceride lipase 16 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (4-nitrophenyl) 4-[bis(1,3-benzodioxol-5-yl)-hydroxymethyl]piperidine-1-carboxylate
INCHI InChI=1S/C27H24N2O9/c30-26(38-21-5-3-20(4-6-21)29(32)33)28-11-9-17(10-12-28)27(31,18-1-7-22-24(13-18)36-15-34-22)19-2-8-23-25(14-19)37-16-35-23/h1-8,13-14,17,31H,9-12,15-16H2
InChi Key SEGYOKHGGFKMCX-UHFFFAOYSA-N
Canonical SMILES C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)(C4=CC5=C(C=C4)OCO5)O)C(=O)OC6=CC=C(C=C6)[N+](=O)[O-]
Isomeric SMILES C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)(C4=CC5=C(C=C4)OCO5)O)C(=O)OC6=CC=C(C=C6)[N+](=O)[O-]
PubChem CID 25021165
Molecular Weight 520.5

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot NumberCertificate TypeDateItem
I2205056Certificate of AnalysisJun 18, 2024 J129444
I2205057Certificate of AnalysisJun 18, 2024 J129444
I2205058Certificate of AnalysisJun 18, 2024 J129444
I2205101Certificate of AnalysisJun 18, 2024 J129444

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 52.05, Max Conc. mM: 100
SensitivityMoisture sensitive.

Related Documents

References

1. Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL et al..  (2009)  Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo..  Proc Natl Acad Sci USA,  106  (48): (20270-5).  [PMID:19918051]
2. Long JZ, Nomura DK, Cravatt BF.  (2009)  Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism..  Chem Biol,  16  (7): (744-53).  [PMID:19635411]
3. Navarro-Romero A et al..  (2022)  Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome..  Elife,  11    [PMID:36217821]
4. Bluett RJ et al..  (2017)  Endocannabinoid signalling modulates susceptibility to traumatic stress exposure..  Nat Commun,  (14782).  [PMID:28348378]

Solution Calculators